Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Aurinia Pharmaceuticals Inc
AUPH
Healthcare
Biotechnology
Aurinia Pharmaceuticals Inc. is a Canada-based fully integrated biopharmaceutical company. The Company is focused on delivering therapies to treat targeted patient populations with a high unmet medical need that are impacted by autoimmune, kidney and rare diseases. The Company has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis...
(LN) and continues to conduct pre-clinical, clinical, and regulatory activities to support the voclosporin development program. LUPKYNIS is a calcineurin inhibitor (CNI) immunosuppressant, that improves near and long-term outcomes in LN when used in combination with mycophenolate mofetil (MMF) and steroids. LUPKYNIS reduces cytokine activation and blocks interleukin IL-2 expression and T-cell mediated immune responses. Voclosporin, the active ingredient in LUPKYNIS, is made by a modification of a single amino acid of the cyclosporine molecule. Its product pipeline includes AUR200 and AUR300.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:AUPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(82)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 18, 2024 11:45am
(AUPH) Investment Analysis and Advice
News; $AUPH (AUPH) Investment Analysis and Advice2024-02-18 11:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize
...more
(82)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 15, 2024 5:30pm
Aurinia Pharmaceuticals Finds No Buyer After Strategic Busin
Just In: $AUPH Aurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock Buyback | BenzingaAurinia Pharmaceuticals Inc@(NASDAQ:AUPH) reported a fourth-quarter 2023 EPS
...more
Q Precious & Battery Metals to Drill Initial 1000 metres at La Corne and McKenzie East Gold Projects, Quebec
posted Apr 23, 2024 9:00am by
Q Precious & Battery Metals Corp
-
|
The Company is planning for an initial 1,000 metres of diamond drilling scheduled for mid- June 2024, with VMS targets on the La Corne South project at proposed depths ranging from 50 to 300 metres below surface as modelled by the EM survey and noted in historic drilling. TMC Geophysique completed deep-penetrating Pulse-EM -Time Domain Electromagnetic (TDEM) surveying on the claims that targeted ...read more
(37)
•••
Apostata
X
View Profile
View Bullboard History
Post by
Apostata
on Dec 15, 2021 4:26pm
Insider Buying
Caught this at the end of today's trading: https://https://newsfilter.io/a/f3900452b2cccee8cead342dda3d2a24m---statement-of-changes-in-beneficial-ownership-of-securities---aurinia
...more
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Post by
ZoranSto
on Dec 09, 2021 12:12pm
More good results
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN) (yahoo.com)
(398)
•••
jboom70
X
View Profile
View Bullboard History
Comment by
jboom70
on Dec 04, 2021 5:59pm
RE:RE:RE:WTH ? Happened today ?
New suitor reported again. Short term price changes are just games with the shorts, they have beat this thing hard and won't let it alone. No matter a BO is a set price. This was designed to sell
...more
(7)
•••
TheRainman
X
View Profile
View Bullboard History
Comment by
TheRainman
on Nov 22, 2021 4:16pm
RE:RE:WTH ? Happened today ?
I also see there was a shite load of insider sales in November , That is not a good sign.
(32)
•••
TimeScape
X
View Profile
View Bullboard History
Comment by
TimeScape
on Nov 22, 2021 3:28pm
RE:WTH ? Happened today ?
Aurinia announced a possible large financing Friday after the close. Obviously, if they are doing a financing, they aren't going to be bought out. The price simply dropped back to what
...more
(7)
•••
TheRainman
X
View Profile
View Bullboard History
Post by
TheRainman
on Nov 22, 2021 3:19pm
WTH ? Happened today ?
I don't get it ?
(398)
•••
jboom70
X
View Profile
View Bullboard History
Comment by
jboom70
on Nov 10, 2021 5:36pm
RE:Still no offer
I'm patient but hope before the end of the year. Lawyers get payed by the hour, LOL
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Post by
ZoranSto
on Nov 09, 2021 11:32am
Still no offer
I think we should get an offer soon...it has been in play for a few days now...I guess lots of negotiating going on behind the scene...
(398)
•••
jboom70
X
View Profile
View Bullboard History
Comment by
jboom70
on Oct 29, 2021 1:40am
RE:RE:RE:RE:RE:RE:Buyout?
Now talk of multiple biders @ +$40
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Comment by
ZoranSto
on Oct 28, 2021 10:21am
RE:RE:RE:RE:RE:Buyout?
Yes that would be great :-)
(32)
•••
TimeScape
X
View Profile
View Bullboard History
Comment by
TimeScape
on Oct 26, 2021 6:37pm
RE:RE:RE:RE:Buyout?
RBC upped their target price from $23 to $34 US today. I'd be pretty happy with that price on a takeover.
(398)
•••
jboom70
X
View Profile
View Bullboard History
Comment by
jboom70
on Oct 26, 2021 5:10am
RE:RE:RE:Buyout?
Current Sp was heavily manipulated by short sellers. Treatment is est @ $62000 yr but Ive also seen $90000as a price. Gets big fast with decent market penetration, say 30% of 300,000 and that's
...more
(32)
•••
TimeScape
X
View Profile
View Bullboard History
Comment by
TimeScape
on Oct 26, 2021 12:51am
RE:RE:Buyout?
The AUPH stock price was $22 before the rumour came out on Friday. A 50% premium would get get it to $33. I doubt an offer would be for much more than that. Maybe $35. AUPH
...more
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study